Company intelligence / Profile preview

Sofimac Innovation

Paris, Île-de-France, France

Ownership: Private
Development stage: Other

Overview

Sofimac Innovation is an independent French venture capital management company approved by the AMF, managing approximately €400 million across multiple funds and investing in more than 80 innovative technology companies, with a particular focus on health and digital sectors.

Industry: Investors

Partnerships

Manages Emergence Innovation II fund, which co-invests with other investors such as Bpifrance and Go Capital in biotech company Igyxos.Co-founding shareholder/investor in Elsalys Biotech alongside Transgene and others.

Beyond the preview

Go deeper on Sofimac Innovation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sofimac Innovation.

Explore the full profile